Study S001547

Harmonizing RCT-Duplicate Emulations: A Real World Replication Program Analyzing Three Clinical Trials, CANVAS, LEADER, and SAVOR TIMI in Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06099067
Acronym: HARRP
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 239990
Start: 2020-05-15
Primary completion: 2023-08-31
Lead sponsor: AstraZeneca
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:Canagliflozin; DRUG:DPP4 inhibitor; DRUG:Liraglutide; DRUG:Saxagliptin; DRUG:2nd generation Sulfonylurea
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

3-point MACE [Follow up begins the day after drug initiation for the three investigated studies [a median of 134-167 days]]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.